Spahn-Langguth, H. Et Al. 1998. P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1 , 16-24.

Spahn-Langguth, H., BAKTIR, G., Radschuweit, A., OKYAR, A., Terhaag, B., Ader, P., ... Hanafy, A.(1998). P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1, 16-24.

Spahn-Langguth, H. Et Al. "P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound," International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1, 16-24, 1998

Spahn-Langguth, H. Et Al. "P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound." International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1, pp.16-24, 1998

Spahn-Langguth, H. Et Al. (1998) . "P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound." International Journal of Clinical Pharmacology and Therapeutics , vol.36, no.1, pp.16-24.

@article{article, author={H. Spahn-Langguth Et Al. }, title={P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound}, journal={International Journal of Clinical Pharmacology and Therapeutics}, year=1998, pages={16-24} }